Achieving good glycemic control: initiation of new antihyperglycemic therapies in patients with type 2 diabetes from the Kaiser Permanente Northern California Diabetes Registry.

@article{Karter2005AchievingGG,
  title={Achieving good glycemic control: initiation of new antihyperglycemic therapies in patients with type 2 diabetes from the Kaiser Permanente Northern California Diabetes Registry.},
  author={Andrew J. Karter and Howard H. Moffet and Jennifer Y. Liu and Melissa M. Parker and Ameena T. Ahmed and Assiamira Ferrara and Joseph Selby},
  journal={The American journal of managed care},
  year={2005},
  volume={11 4},
  pages={262-70}
}
OBJECTIVE To compare the effectiveness of antihyperglycemic therapies in type 2 diabetic patients with poor glycemic control (baseline glycosylated hemoglobin [HbA1C] > 8%). STUDY DESIGN Longitudinal (cohort) study. METHODS Study patients were 4775 type 2 diabetic patients who initiated new antihyperglycemic therapies and maintained them for up to 1 year. The study setting was Kaiser Permanente Northern California Medical Group, an integrated, prepaid, healthcare delivery organization… CONTINUE READING